Selected Publications

Juhasz V, Quinaglia T, Drobni ZD, Gilman HK, Heemelaar JC, Neuberg DS, Han Y, Ky B, Kwong RY, Januzzi JL, Asnani A, Redd RA, Mousavi N, Jerosch-Herold M, Scherrer-Crosbie M, Neilan TG.: Atorvastatin and left ventricular strain during anthracycline-based chemotherapy. Int J Cardiol 454: 134439, Jul 2026.

Zaghlol R, Deych E, Ladin DA, Russler-Germain DA, Schiffer W, Baral N, Waken RJ, Ky B, Joynt Maddox KE, Mitchell JD.: Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries. Eur Heart J May 2026.

Meng X, Eulalio T, Oh K, Plonski NM, Shelton K, Mulder HL, Easton J, Zhang J, Walker EV, Neale G, Srivastava DK, Howell RM, Mandelblatt JS, Ky B, Dixon SB, Armstrong GT, Hudson MM, Ness KK, Wang Z.: Cancer Treatment-Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration. Cancer Epidemiol Biomarkers Prev 35: 718-727, May 2026.

Selvakumar S, Shetty S, Sharma AB, Zahra FT, Wang E, Koelmeyer H, Carver J, Fradley MG, Jung W, Ky B, Lefebvre B, Scherrer-Crosbie M, Wilcox NS, Wu KY, Chan O, Xie Z, Kuykendall AT, Sallman DA, Padron E, Alomar M, Cleveland JL, Mo Q, Komrokji R, Lancet JE, Yun S, Lee DH.: Cardiovascular Adverse Events During Venetoclax-Based Treatment in Acute Myeloid Leukemia. J Am Heart Assoc 15: e048790, May 2026.

Ky B, Liu T, Margulies KB, Mitchell JD, Haas NB, Gareen IF, Thangarajah M, Sicks JD, Domenico C, Narayan VK, Smith AM, Wilcox NS, Mittal K, Rhee JW, Armenian SH, Saphner T, Paul AK, Gartrell BA, Zaha VG, Anari F, Wong RL, Townsend RR, Wagner LI.: Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191. Hypertension May 2026.

Szewczyk W, Reding KW, D'Agostino RB Jr, Cheng RK, Palesh O, Olson K, Ladd A, Weaver KE, Ky B, Hundley WG.: Association of sleep disturbance during breast cancer treatment and left ventricular ejection fraction decline: a prospective cohort study. Cardiooncology 12: 37, Feb 2026.

Rodrigues JL, O'Connell NS, Sutton AL, Ruddy KJ, Weaver KE, Lesser GJ, Ky B, D'Agostino RB Jr, Hundley WG, Bellissimo MP.: Muscle quality during cancer treatment and associations with health-related quality of life. Qual Life Res 35: 71, Feb 2026.

Eulalio T, Kim Y, Meng X, Plonski NM, Shelton K, Mulder H, Plyler E, Easton J, Chen X, Zhang J, Walker E, Neale G, Ni M, Lucas JT Jr, Chatterjee N, Wang Z, Srivastava D, Ky B, Dixon SB, Ness KK, Hudson MM, Armstrong GT, Wang Z.: Epigenome-wide analysis identifies DNA methylation mediators of treatment-related cardiometabolic risk in survivors of childhood cancer. Nat Commun 17: 1979, Jan 2026.

Jung W, Ko K, Smith AM, Huang A, Xia C, Martei YM, Narayan VK, Clark AS, Lefebvre B, McDermott K, Koropeckyj-Cox D, Fasan O, Hutsell A, Daniels A, Englefield V, Leger KJ, Getz KD, Narayan HK, Marshall JD, Powell-Wiley TM, Yancy CW, Ky B.: Air Pollution and Cardiac Remodeling and Function in Patients With Breast Cancer. JAMA Netw Open 9: e2552323, Jan 2026.

Afari H, Xia C, Mwita J, Moshomo T, Huang A, Shaikh M, Motlhwa SW, Ralefala T, Vuylsteke P, Dryden-Peterson S, Hsue PY, Gross R, Mosepele M, Ky B, Martei YM.: Cardiovascular risk factors and cardiac dysfunction in people with HIV and breast cancer: an observational cohort study in Botswana. Cardiooncology 12: 9, Jan 2026.